Impact of metabolic syndrome on cognitive decline in older age: Protective or harmful, where is the pitfall?

Journal of Alzheimer's Disease

Volumn 41, Issue 1, 2014, Pages 163-167

  Frisardi, Vincenza ^a,b  

^a Istituto Geriatrico Camillo Golgi   (Italy)

^b 'Golgi Cenci' Foundation   (Italy)

Author keywords

Alzheimer's disease; dementia; late life cognitive decline; metabolic syndrome

Indexed keywords

AGING; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; HUMAN; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELIABILITY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); COGNITION; FEMALE; MALE; METABOLIC DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; COGNITION; FEMALE; HUMANS; MALE; METABOLIC DISEASES;

EID: 84902252612     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140389     Document Type: Review

References (26)

1. Frisardi V, Imbimbo BP (2012) Metabolic-cognitive syndrome: Metabolic approach for the management of Alzheimer's disease risk. J Alzheimers Dis 30 (Suppl 2), S1-S4.
2. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin- likegrowthfactorexpression andsignaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 7, 63-80.
3. Stranahan AM, Mattson MP (2012) Metabolic reserve as a determinant of cognitive aging. J Alzheimers Dis 30 (Suppl 2), S5-S13.
4. Frisardi V, Panza F, Seripa D, Farooqui T, Farooqui AA (2011) Glycerophospholipids and glycerophospholipid-derived lipid mediators: A complex meshwork in Alzheimer's disease pathology. Prog Lipid Res 50, 313-330.
5. Little JP, Madeira JM, Klegeris A (2012) The saturated fatty acid palmitate induces human monocytic cell toxicity toward neuronal cells: Exploring a possible link between obesity-related metabolic impairments and neuroinflamma-tion. J Alzheimers Dis 30 (Suppl 2), S179-S183.
6. Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E, Santos MS, Oliveira CR, Moreira PI (2012) Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation. Brain Res 1441, 64-78.
7. Panza F, Solfrizzi V, Logroscino G, Maggi S, Santamato A, Seripa D, Pilotto A (2012) Current epidemiolog-ical approaches to the metabolic-cognitive syndrome. J Alzheimers Dis 30 (Suppl 2), S31-S75.
8. Siervo M, Harrison SL, Jagger C, Robinson L, Stephan BC (2014) Metabolic syndrome and longitudinal changes in cognitive function: A systematic review and meta-analysis. J Alzheimers Dis 41 (1), 151-161.
9. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292, 2237-2242.
10. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N (2007) Metabolic syndrome and cognitive decline in elderly Latinos: Findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55, 758-762.
11. Ho RC, Niti M, Yap KB, Kua EH, Ng TP (2008) Metabolic syndrome and cognitive decline in chinese older adults: Results from the singapore longitudinal ageing studies. Am J Geriatr Psychiatry 16, 519-522.
12. Feng L, Chong MS, Lim WS, Lee TS, Collinson SL, Yap P, Ng TP (2013) Metabolic syndrome and amnestic mild cognitive impairment: Singapore Longitudinal Ageing Study-2 findings. J Alzheimers Dis 34, 649-657.
13. Akbaraly TN, Kivimaki M, Shipley MJ, Tabak AG, Jokela M, Virtanen M, Marmot MG, Ferrie JE, Singh-Manoux A (2010) Metabolic syndrome over 10 years and cognitive functioning in late midlife: The Whitehall II study. Diabetes Care 33, 84-89.
14. Clark F, Jackson J, Carlson M, Chou CP, Cherry BJ, Jordan-Marsh M, Knight BG, Mandel D, Blanchard J, Granger DA, Wilcox RR, Lai MY, White B, Hay J, Lam C, Marterella A, Azen SP (2012) Effectiveness of a lifestyle intervention in promoting the well-being of independently living older people: Results of the Well Elderly 2 Randomised Controlled Trial. Epidemiol Community Health 66, 782-790.
15. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R (2007) Metabolic syndrome and cognitive function:A population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 23, 29-34.
16. Raffaitin C, Féart C, Le Goff M, Amieva H, Helmer C, Akbaraly TN, Tzourio C, Gin H, Barberger-Gateau P (2011) Metabolic syndrome and cognitive decline in French elders: The Three-City Study. Neurology 76, 518-525.
17. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F; Italian Longitudinal Study on Aging Working Group (2011) Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging 32, 1932-1941.
18. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, West-endorp RG (2007) The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 69, 979-985.
19. Katsumata Y, Todoriki H, Higashiuesato Y, Yasura S, Willcox DC, Ohya Y, Willcox BJ, Dodge HH (2012) Metabolic syndrome and cognitive decline among the oldest oldin Okinawa: In search of a mechanism. KOCOA Project. The J Gerontol A Biol Sci Med Sci 67, 126-134.
20. Winter JE, Macinnis RJ, Wattanapenpaiboon N, Nowson CA (2014) BMI and all-cause mortality in older adults: A meta-analysis. The Am J Clin Nutr. doi: 10.3945/ajcn.113.068122 (epub ahead of print)
21. Heiat A, Vaccarino V, Krumholz HM (2001) An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 161, 1194-1203.
22. Klenk J, Rapp K, Ulmer H, Concin H, Nagel G (2014) Changes of body mass index in relation to mortality: Results of a cohort of 42, 099 adults. PLoS One 9, e84817.
23. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC; Dominantly Inherited Alzheimer Network (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367, 795-804.
24. Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group (2013) Amyloid fj deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurol 12, 357-367.
25. Morrison JH1, Hof PR (1997) Life and death of neurons in the aging brain. Science 278, 412-419.
26. Scheff SW, Neltner JH, Nelson PT (2014) Is synaptic loss a unique hallmark of Alzheimer's disease? Biochem Pharmacol 9, pii: S0006-2952 (14) 00003-3, doi: 10.1016/j.bcp.2013.12.028 (epub ahead of print)